贝达药业股价涨5.24%，天治基金旗下1只基金重仓，持有9400股浮盈赚取3.48万元

Group 1 - Benda Pharmaceutical's stock increased by 5.24% to 74.37 CNY per share, with a trading volume of 633 million CNY and a turnover rate of 2.09%, resulting in a total market capitalization of 31.29 billion CNY [1] - Benda Pharmaceutical, established on January 7, 2003, and listed on November 7, 2016, primarily engages in the research, production, and sales of pharmaceuticals, with 99.10% of its revenue coming from drug sales and 0.90% from other sources [1] Group 2 - Tianzhi Fund holds a significant position in Benda Pharmaceutical, with its Tianzhi New Consumption Mixed Fund (350008) owning 9,400 shares, accounting for 2.9% of the fund's net value, making it the second-largest holding [2] - The Tianzhi New Consumption Mixed Fund was established on August 4, 2011, with a current size of 18.77 million CNY, achieving a year-to-date return of 6.86% and a one-year return of 4.62% [2] Group 3 - The fund manager of Tianzhi New Consumption Mixed Fund is Liang Li, who has been in the position for 4 years and 141 days, with the fund's total assets amounting to 71.05 million CNY [3] - During Liang Li's tenure, the best fund return was 11.55%, while the worst return was -60.72% [3]